Diagnosing immune-mediated reactions to drugs (Q37484366)

20 August 2017

1 reference

title

Diagnosing immune-mediated reactions to drugs (English)

1 reference

20 August 2017

Nagao-Dias AT

1

1 reference

20 August 2017

Teixeira FM

series ordinal

2

1 reference

20 August 2017

Coelho HL

series ordinal

3

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Allergologia et Immunopathologia

20 August 2017

published in

1 reference

20 August 2017

volume

37

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

98-104

1 reference

Introduction of a practice guideline for penicillin skin testing improves the appropriateness of antibiotic therapy

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Epidemiology of hypersensitivity drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

1 reference

7 January 2021

Anaphylactic reactions--value of skin and provocation tests

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Adverse reactions to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Anaphylaxis During the Perioperative Period

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Pathogenesis of drug-induced exanthems

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Penicillin allergy: consider trying penicillin again

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Clinical presentation and time course in hypersensitivity reactions to beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Clinical practice. Antibiotic allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Diagnosis and management of penicillin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Pharmacist-managed service providing penicillin allergy skin tests

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

1 reference

7 January 2021

Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate ?-lactam allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Patients with drug reactions -- is it worth testing?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

In vitro allergy diagnosis: should we follow the flow?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Flow-assisted allergy diagnosis: current applications and future perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Cellular tests in the diagnosis of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Recent advances in the diagnosis of drug allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2809%2971112-7

7 January 2021

10.1016/S0301-0546(09)71112-7

Identifiers

DOI

1 reference

20 August 2017

1 reference